Successful Treatment of Bacteremia and Ventilator-Associated Pneumonia Caused by KPC/OXA-48-like Klebsiella pneumoniae Co-Producer with a Continuous Infusion of High-Dose Meropenem Plus Fosfomycin Guided by Real-Time Therapeutic Drug Monitoring

Bacteremia and ventilator-associated pneumonia due to a pan-resistant Klebsiella pneumoniae strain co-producing KPC and OXA-48 carbapenemases was successfully treated in a COVID-19 critically ill patient with a combination therapy of a high-dose continuous infusion of meropenem (up to 3 g every 6 h,...

Descripción completa

Detalles Bibliográficos
Autores principales: Cojutti, Pier Giorgio, Fornaro, Giacomo, Gatti, Milo, Rinaldi, Matteo, Gaibani, Paolo, Giannella, Maddalena, Pea, Federico, Viale, Pierluigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8872245/
https://www.ncbi.nlm.nih.gov/pubmed/35200438
http://dx.doi.org/10.3390/idr14010010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8872245/
https://www.ncbi.nlm.nih.gov/pubmed/35200438
http://dx.doi.org/10.3390/idr14010010

Ejemplares similares